Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell From Jefferies
Kepler Capital Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care Analyst Ratings
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Cuts Target Price to $22
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), IGC Pharma (IGC) and Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
Fresenius Medical Care to Achieve Operating Income Margin of 10% to 14% by 2025 >FMS
Press Release: Fresenius Medical Care Delivers Continued Operating Income Improvements in the Second Quarter of 2024
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell From J.P. Morgan
Fresenius Medical Care Had Seen 2024 Operating Income to Grow Mid- to High-Teens
J.P. Morgan Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Deutsche Numis Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank Remains a Buy on Fresenius Medical Care AG & Co. KGaA (0H9X)
Goldman Sachs Sticks to Its Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Truist Securities: Maintaining the Fresenius Medical Care (FMS.US) rating, adjusted from holding to holding rating, and adjusted target price from $21.00 to $24.00.
Fresenius Medical Care Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Fresenius Medical Care (FMS)
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $21, Maintains Hold Rating
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care